Octasa · DIN 02465752 · 800 mg · DR tablet
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Octasa · DIN 02465752
Manufacturer: Tillotts Pharma AG; listing date 2024-04-30
Health Canada: Marketed since 2022-09-28 · brand OCTASA · ATC A07EC02 MESALAZINE · form Tablet (delayed-release) · route Oral · ingredients MESALAZINE 800 MG · company Tillotts pharma ag · schedule Prescription
Octasa: Formulary list price $1.14 per unit (the source does not state the unit; exact figure $1.1358). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02465752)
Source record
DIN 02465752: Octasa
Raw flags: sec3=Y
Item: 564000143; group id 682; item number 1699; lccId None; manufacturer id TIP
Source form: DR Tab; strength: 800mg
Recorded listing: General benefit
Source prices (unrounded): $1.1358; ministry $1.1358
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02465752
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95399
Shortage status: not checked (no credentials)